<DOC>
	<DOC>NCT00446082</DOC>
	<brief_summary>This study will assess the pharmacokinetic profile and the safety/tolerability profile of single and monthly doses of pasireotide LAR intramuscular (i.m.) injection in patients with acromegaly and patients with carcinoid disease</brief_summary>
	<brief_title>Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease</brief_title>
	<detailed_description />
	<mesh_term>Carcinoid Tumor</mesh_term>
	<mesh_term>Acromegaly</mesh_term>
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<criteria>Inclusion criteria for patients with acromegaly: Male or female patients between 18 and 80 years Patients with acromegaly due to a pituitary adenoma with elevated GH and IGF1 concentrations Exclusion criteria for patients with acromegaly: Patients with compression of the optic chiasm causing any visual field defect Specific criteria apply for patients who have received certain types of therapies such as radiotherapies, surgeries, chemo or immunotherapies in the months prior to study start Female patients who are pregnant or lactating Inclusion criteria for patients with carcinoid disease: Male or female patients aged â‰¥18 years Patients with histologically confirmed, metastatic carcinoid tumors of the digestive system Patients with elevation of chromograninA (CgA) and/or serotonin Patients who are not adequately controlled by somatostatin analogues Exclusion criteria for patients with carcinoid disease: Specific criteria apply for patients who have received certain types of therapies such as radiotherapies, surgeries, chemo or immunotherapies in the months prior to study start Female patients who are pregnant or lactating Other protocoldefined in and exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Refractory/ resistant carcinoid disease</keyword>
	<keyword>acromegaly</keyword>
	<keyword>adults</keyword>
	<keyword>pasireotide LAR</keyword>
	<keyword>somatostatin analogue</keyword>
	<keyword>SOM230</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>Refractory or resistant carcinoid disease and acromegaly</keyword>
</DOC>